In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer
17 páginas, 7 figuras.
| Autores: | , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/377901 |
| Acesso em linha: | http://hdl.handle.net/10261/377901 |
| Access Level: | acceso abierto |
| Palavra-chave: | CAFs CBD EMT NFs THC TME Cannabinoid agonists Lung cancer |
| id |
ES_d05afc5ccbae480f71f0cd59d51f0c3d |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/377901 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer |
| title |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer |
| spellingShingle |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer Milián, Lara CAFs CBD EMT NFs THC TME Cannabinoid agonists Lung cancer |
| title_short |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer |
| title_full |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer |
| title_fullStr |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer |
| title_full_unstemmed |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer |
| title_sort |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer |
| dc.creator.none.fl_str_mv |
Milián, Lara Monleón-Guinot, Irene Sancho-Tello, María Galbis, José Marcelo Cremades, Antonio Almenar-Ordaz, María Peñaroja-Martínez, Josep Farràs, Rosa Martín de Llano, José Javier Carda, Carmen Mata-Campuzano, Manuel |
| author |
Milián, Lara |
| author_facet |
Milián, Lara Monleón-Guinot, Irene Sancho-Tello, María Galbis, José Marcelo Cremades, Antonio Almenar-Ordaz, María Peñaroja-Martínez, Josep Farràs, Rosa Martín de Llano, José Javier Carda, Carmen Mata-Campuzano, Manuel |
| author_role |
author |
| author2 |
Monleón-Guinot, Irene Sancho-Tello, María Galbis, José Marcelo Cremades, Antonio Almenar-Ordaz, María Peñaroja-Martínez, Josep Farràs, Rosa Martín de Llano, José Javier Carda, Carmen Mata-Campuzano, Manuel |
| author2_role |
author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Ministerio de Economía y Competitividad (España) Generalitat Valenciana Asociación Española Contra el Cáncer Instituto de Salud Carlos III European Commission Farràs, Rosa [0000-0003-4931-1494] |
| dc.subject.none.fl_str_mv |
CAFs CBD EMT NFs THC TME Cannabinoid agonists Lung cancer |
| topic |
CAFs CBD EMT NFs THC TME Cannabinoid agonists Lung cancer |
| description |
17 páginas, 7 figuras. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/377901 |
| url |
http://hdl.handle.net/10261/377901 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-106099RB-C42 https://doi.org/10.3390/ijms23126766 No |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869420167057899520 |
| spelling |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung CancerMilián, LaraMonleón-Guinot, IreneSancho-Tello, MaríaGalbis, José MarceloCremades, AntonioAlmenar-Ordaz, MaríaPeñaroja-Martínez, JosepFarràs, RosaMartín de Llano, José JavierCarda, CarmenMata-Campuzano, ManuelCAFsCBDEMTNFsTHCTMECannabinoid agonistsLung cancer17 páginas, 7 figuras.There is evidence that demonstrates the effect of cannabinoid agonists inhibiting relevant aspects in lung cancer, such as proliferation or epithelial-to-mesenchymal transition (EMT). Most of these studies are based on evidence observed in in vitro models developed on cancer cell lines. These studies do not consider the complexity of the tumor microenvironment (TME). One of the main components of the TME is cancer-associated fibroblasts (CAFs), cells that are relevant in the control of proliferation and metastasis in lung cancer. In this work, we evaluated the direct effects of two cannabinoid agonists, tetrahydrocannabinol (THC) and cannabidiol (CBD), used alone or in combination, on CAFs and non-tumor normal fibroblasts (NFs) isolated from adenocarcinoma or from healthy lung tissue from the same patients. We observed that these compounds decrease cell density in vitro and inhibit the increase in the relative expression of type 1 collagen (COL1A1) and fibroblast-specific protein 1 (FSP1) induced by transforming growth factor beta (TGFβ). On the other hand, we studied whether THC and CBD could modulate the interactions between CAFs or NFs and cancer cells. We conditioned the culture medium with stromal cells treated or not with THC and/or CBD and cultured A549 cells with them. We found that culture media conditioned with CAFs or NFs increased cell density, induced morphological changes consistent with EMT, inhibited cadherin-1 (CDH1) gene expression, and induced an increase in the relative expression of cadherin-2 (CDH2) and vimentin (VIM) genes in A549 cells. These changes were inhibited or decreased by THC and CBD administered alone or in combination. In another series of experiments, we conditioned culture media with A549 cells treated or not with THC and/or CBD, in the presence or absence of TGFβ. We observed that culture media conditioned with A549 in the presence of TGFβ induced an increase in the expression of COL1A1 and VIM, both in CAFs and in non-tumor NFs. Both THC and CBD ameliorated these effects. In summary, the results presented here reinforce the usefulness of cannabinoid agonists for the treatment of some relevant aspects of lung cancer pathology, and demonstrate in a novel way their possible effects on CAFs as a result of their relationship with cancer cells. Likewise, the results reinforce the usefulness of the combined use of THC and CBD, which has important advantages in relation to the possibility of using lower doses, thus minimizing the psychoactive effects of THC.This work was supported by grant PID2019-106099RB-C42 (MM) from the Ministry of Economy and Competitiveness of the Spanish Government, by grant PROMETEO/2020/069 (CC) from the local government of the Comunitat Valenciana (Spain), by grant AECC (Asociación Española Contra el Cáncer) and by Fondo de Investigación Sanitaria, ISCIII, grant number PI20-194, co-funded by ERDF/ESF, “Investing in your future”. CIBER-BBN and CIBERER are financed by the VI National R&D&I Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and the Instituto de Salud Carlos III, with the assistance of the European Regional Development Fund.Peer reviewedMultidisciplinary Digital Publishing InstituteMinisterio de Economía y Competitividad (España)Generalitat ValencianaAsociación Española Contra el CáncerInstituto de Salud Carlos IIIEuropean CommissionFarràs, Rosa [0000-0003-4931-1494]202520252022info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/377901reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-106099RB-C42https://doi.org/10.3390/ijms23126766Noinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3779012026-05-22T06:33:51Z |
| score |
15.812429 |